| Structure |
Chemical Name |
CAS |
MF |
 |
Lincomycin EP Impurity B |
37744-65-3 |
C18H32N2O6S |
 |
pidotiMod iMpurity E |
162148-16-5 |
C9H12N2O4S |
![methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/58000-63-8.gif) |
methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
58000-63-8 |
C21H26N2O3 |
 |
ヒドロキシチオバルデナフィル |
912576-30-8 |
C23H32N6O4S2 |
 |
アンドロスタ-3,5-ジエン-17-オン |
1912-63-6 |
C19H26O |
![2-エチルアミノ-1-[4-(2-メトキシエチル)フェノキシ]エタノール](/CAS/GIF/109632-08-8.gif) |
2-エチルアミノ-1-[4-(2-メトキシエチル)フェノキシ]エタノール |
109632-08-8 |
C14H23NO3 |
 |
3-(アミノスルホニル)-5-(ブチルアミノ)-4-フェノキシ安息香酸ブチル |
32643-00-8 |
C21H28N2O5S |
 |
Bendamustine Related Impurity 12 |
|
|
|
|
(S)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)thio)ethyl)amino)-3-hydroxy-4-oxobutanoic acid |
|
|
|
|
Dasatinib Impurity 24 |
|
|
|
|
Trelagliptin Impurity 21 |
|
|
![4-[1-(4-クロロフェニル)-1-フェニルエトキシ]-1-メチルヘキサヒドロ-1H-アゼピン](/CAS/GIF/61771-18-4.gif) |
4-[1-(4-クロロフェニル)-1-フェニルエトキシ]-1-メチルヘキサヒドロ-1H-アゼピン |
61771-18-4 |
C21H26ClNO |
|
|
Apixaban Impurity 78 |
|
|
 |
Sitafloxacin Impurity 3 |
|
C23H10Cl2F4N2O6 |
 |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-81-7 |
C19H24N4O3 |
 |
(1s,4s)-4-((2-amino-3-bromobenzyl)amino)cyclohexan-1-ol hydrochloride |
|
C13H20BrClN2O |
|
|
Brivaracetam Impurity 47 |
2755924-55-9 |
|
 |
Vildagliptin Impurity ZA6 |
2246354-69-6 |
C17H23N3O2 |
|
|
AtracuriuM Besylate IMpurity D Iodide (Mixture of DiastereoMers) |
|
|
|
|
Sitafloxacin Impurity 18 |
|
|
 |
Olaparib impurity 1 |
763113-06-0 |
C24H24N4O3 |
|
|
Ticagrelor Impurity 104 |
|
|
|
|
Tofacitinib Impurity 69 |
|
|
 |
Avibactam Impurity 15 |
1416134-60-5 |
C15H20N2O3 |
|
|
Carbocistein Impurity C |
|
|
|
|
Landiolol impurity Z |
|
|
 |
Medetomidine Impurity 52 |
128366-51-8 |
C13H14N2O2 |
 |
Valsartan Impurity 12 |
1189547-11-2 |
C11H21NO3 |
 |
Acarbose Impurity IV (JP) |
|
C13H21NO7 |
|
|
Lincomycin sulfone Impurity 2 |
|
|
 |
Lamivudine Impurity 7 |
147126-63-4 |
C14H24O4S |
|
|
Nintedanib Impurity 26 |
|
|
 |
Pralatrexate Impurity 8 |
112408-16-9 |
C8H15NO4 |
 |
Brexpiprazole Impurity 20 |
1420987-85-4 |
C20H20N2S2 |
 |
Rosuvastatin Impurity 89 |
2226413-61-0 |
C38H46F2N6O9S2 |
|
|
Rosuvastatin Impurity 53 |
|
|
 |
N,N-bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide |
2514957-29-8 |
C27H22F2N4O2S |
 |
Imiquimod Impurity 5 |
853793-02-9 |
C15H18N4 |
|
|
Topiroxostat Impurity Ⅱ-3 |
|
|
![(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride](/CAS/GIF/1217655-87-2.gif) |
(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride |
1217655-87-2 |
C25H25ClFNO3 |
|
|
Fesoterodine Impurity 12 |
|
|
 |
2-isonicotinoyl-5,6-diMethoxy-2,3-dihydro-1H-inden-1-one |
923571-15-7 |
C17H15NO4 |
 |
Aatrombopag Impurity 17 |
1268118-96-2 |
C7H4BrClN2S2 |
 |
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
|
|
Meropenem IMP B |
|
|
|
|
Cinacalcet impurity K |
|
|
 |
DL-2-(4-Carboxyphenyl)propionic Acid |
67381-50-4 |
C10H10O4 |
 |
レニウム |
7440-15-5 |
Re |
|
|
Apixaban Impurity 32 |
|
|
|
|
Fulvestrant impurityABCDEFGHJKL |
|
|
 |
1-(3,5-bis(benzyloxy)phenyl)-2,2-dibromoethan-1-one |
|
C22H18Br2O3 |
 |
Empagliflozin Impurity 82 |
2452301-16-3 |
C17H16ClIO2 |
 |
myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside |
142449-93-2 |
C26H28O17 |
 |
Daclatasvir Impurity 5 (SRSS-Isomer) |
1009117-28-5 |
C40H50N8O6 |
|
|
Aprepitant iMpurity A |
|
|
 |
Hydroxy Varenicline |
357424-21-6 |
C13H13N3O |
 |
8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-7-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2365490-44-2 |
C13H8ClF2NO4 |
 |
Dapagliflozin Impurity 165 |
342043-51-0 |
C18H18O4 |
|
|
Oseltamivir Impurity 81 |
|
|
 |
1,3-ビス(9H-カルバゾール-4-イルオキシ)-2-プロパノール(CARVEDILOL IMPURITY) |
1276477-91-8 |
C27H22N2O3 |
 |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
|
|
ceftazidiMe iMpurity E |
|
|
|
|
Amylmetacresol EP impurity E |
|
|
 |
エリスロ-グアイアシルグリセロール β-シナピルエーテル7-O-ルグルコシド |
412029-03-9 |
C27H36O13 |
|
|
N-Nitroso Aprocitentan |
|
|
 |
Ibrutinib Impurity 3 |
1226872-27-0 |
C25H26N6O4 |
 |
2-(4-HYDROXY-PHENYL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID |
886501-78-6 |
C11H9NO3S |
|
|
Orforglipron impurity 33 |
|
|
 |
2-(3-クロロ-2-ヒドロキシプロピル)-2H-イソインドール-1,3-ジオン |
19667-37-9 |
C11H10ClNO3 |
![5'-デオキシ-5-フルオロ-N-[(2-メチルブトキシ)カルボニル]シチジン](/CAS/GIF/910129-15-6.gif) |
5'-デオキシ-5-フルオロ-N-[(2-メチルブトキシ)カルボニル]シチジン |
910129-15-6 |
C15H22FN3O6 |
|
|
Aprepitant Impurity 34 |
|
|
|
|
Sofosbuvir Impurity 5 |
|
|
![Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib](/CAS/GIF/910297-71-1.gif) |
Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib |
910297-71-1 |
C16H13Cl2N5O2S |
 |
1,2,3,4-Tetrahydro-4,8-dihydroxy-2-methyl-isoquinoline |
23824-25-1 |
C10H13NO2 |
 |
2-Keto-D-gulonic Acid Methyl Ester |
67776-07-2 |
C7H12O7 |
 |
3,5,7-トリメチル-1-アダマンタンアミン・塩酸塩 |
15210-60-3 |
C13H24ClN |
![1-[2-[(5-chloro-2,4-diMethylphenyl)thio]phenyl]- Piperazine](/CAS/20150408/GIF/1240670-87-4.gif) |
1-[2-[(5-chloro-2,4-diMethylphenyl)thio]phenyl]- Piperazine |
1240670-87-4 |
C18H21ClN2S |
 |
Methylene-Bis Paroxetine |
1292846-10-6 |
C39H40F2N2O6 |
 |
latanoprost iMpurity |
733036-95-8 |
C25H35FO5 |
|
|
Alvimopan Impurity 3 |
|
|
|
|
Exemestane Impurity A |
|
|
|
|
Fasudil iMpurity C |
|
|
|
|
sofosBuvir impurity 49 |
|
|
|
|
Nettopitan impurity |
|
|
 |
(S)-キヌクリジン-3-アミン |
120570-05-0 |
C7H14N2 |
 |
5-クロロ-N-(4,5-ジヒドロ-1H-イミダゾール-2-イル)キノキサリン-6-アミン |
91147-46-5 |
C11H10ClN5 |
![L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1)](/CAS/20211123/GIF/1194550-65-6.gif) |
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
|
|
Amifostine Impurity 1 |
|
|
|
|
(2R,3R)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-methyl-3-(trifluoromethyl)phenyl)piperidine-3-carboxamide |
|
|
![(1R,1'R,2S,2'S)-2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium Benzenesulfonate](/CAS/20210111/GIF/96946-46-2.gif) |
(1R,1'R,2S,2'S)-2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium Benzenesulfonate |
96946-46-2 |
C59H77N2O15S+ |
 |
2-(1,3,2-Dioxaborinan-2-yl)benzamide |
2377611-18-0 |
C10H12BNO3 |
|
|
Afatinib Impurity YHQ |
|
|
![(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine](/CAS/20150408/GIF/38284-47-8.gif) |
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine |
38284-47-8 |
C17H31NO2 |
|
|
Gadobutrol Impurity 20 |
3010287-09-6 |
|
|
|
Lesinurad Impurity |
|
|
 |
2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール |
745767-97-9 |
C18H31NO2 |
![1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-](/CAS/20180808/GIF/344418-92-4.gif) |
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- |
344418-92-4 |
C16H20N6O |
 |
(D-LYS16)-ACTH (1-24) (ヒト, ウシ, マウス, ヒツジ, ブタ, ウサギ, ラット) |
494750-52-6 |
C136H210N40O31S |
|
|
Quetiapine EP Impurity Q |
|
|
 |
N1-Methylbenzene-1,2,4-triaMine |
60651-29-8 |
C7H11N3 |